Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.61 |
| ▸ | CA12 | O43570 | 2/20 | 0.55 |
| ▸ | CA9 | Q16790 | 2/20 | 0.55 |
| ▸ | CA3 | P07451 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
| ▸ | CA6 | P23280 | 1/20 | 0.55 |
| ▸ | CA5A | P35218 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL29090059 | 0.89 | IDO1 (0.51) | IDO1CA12CA9CA3CA4 | |
| SCHEMBL13736441 | 0.86 | MAPT (0.57) | IDO1CA12CA9CA3CA4 | |
| SCHEMBL9577809 | 0.84 | MAPT (0.55) | IDO1CA12CA9CA3CA4 | |
| SCHEMBL5362698 | 0.82 | MAPT (0.53) | IDO1CA12CA9CA3CA4 | |
| SCHEMBL28927027 | 0.82 | MAPT (0.53) | IDO1CA12CA9CA3CA4 | |
| SCHEMBL14895469 | 0.81 | IDO1 (0.44) | IDO1CA12CA9CA3CA4 | |
| SCHEMBL2204571 | 0.80 | KDM4E (0.52) | IDO1CA12CA9CA3CA4 | |
| SCHEMBL3081628 | 0.80 | MEN1 (0.53) | IDO1CA12CA9CA3CA4 | |
| SCHEMBL3081625 | 0.80 | MEN1 (0.53) | IDO1CA12CA9CA3CA4 | |
| SCHEMBL8751587 | 0.78 | MAPT (0.50) | IDO1CA12CA9CA3CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118307410-A | Preparation method of chiral secondary alcohol compound | 武汉大学 | 2024-07-09 | — | — | CN | claimed |
| CN-118063389-A | Process for preparing imidazole derivatives | 远大医学营养科学(武汉)有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-113372238-B | Imine compound and its synthesis method and use | 上海科技大学 | 2022-09-23 | — | — | CN | claimed |
| CN-113372238-A | Imine compound and its synthesis method and use | 上海科技大学 | 2021-09-10 | — | — | CN | claimed |
| US-4481141-A | COLOR PHOTOGRAPHJY, DIFFUSION TRANSFER | EASTMAN KODAK COMPANY (US) | 1984-11-06 | — | — | US | claimed |
| US-4418131-A | Photographic products and processes employing novel nondiffusible yellow dye-releasing compounds and precursors thereof | EASTMAN KODAK COMPANY (US) | 1983-11-29 | — | — | US | claimed |
| US-4407931-A | DIFFUSION TRANSFER | EASTMAN KODAK COMPANY (US) | 1983-10-04 | — | — | US | claimed |
| US-12037405-B2 | Anti-CD70 antibody drug conjugates | AMBRX, INC. | 2024-07-16 | — | — | US | disclosed |
| CN-118307410-A | Preparation method of chiral secondary alcohol compound | 武汉大学 | 2024-07-09 | — | — | CN | disclosed |
| CN-118063389-A | Process for preparing imidazole derivatives | 远大医学营养科学(武汉)有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-117280489-A | Positive electrode mixture, positive electrode, and secondary battery | 大金工业株式会社 | 2023-12-22 | — | — | CN | disclosed |
| CN-117223122-A | Positive electrode mixture, positive electrode, and secondary battery | 大金工业株式会社 | 2023-12-12 | — | — | CN | disclosed |
| CN-117223123-A | Positive electrode mixture, positive electrode, and secondary battery | 大金工业株式会社 | 2023-12-12 | — | — | CN | disclosed |
| EP-0097849-B1 | PHOTOGRAPHIC RECORDING MATERIAL EMPLOYING A NONDIFFUSIBLE YELLOW DYE-RELEASING COMPOUND | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1986-09-10 | — | — | EP | disclosed |
| EP-0135017-A1 | Process for the stabilisation of poly(phenylene ether) solutions | BASF Aktiengesellschaft (DE) | 1985-03-27 | — | — | EP | disclosed |
| US-4481141-A | COLOR PHOTOGRAPHJY, DIFFUSION TRANSFER | EASTMAN KODAK COMPANY (US) | 1984-11-06 | — | — | US | disclosed |
| EP-0116955-A2 | Complexes of (1,2-diphenyl-ethylene diamine) platinum (II) | Degussa Aktiengesellschaft (DE) | 1984-08-29 | — | — | EP | disclosed |
| EP-0097849-A2 | Photographic recording material employing a nondiffusible yellow dye-releasing compound | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1984-01-11 | — | — | EP | disclosed |
| US-4418131-A | Photographic products and processes employing novel nondiffusible yellow dye-releasing compounds and precursors thereof | EASTMAN KODAK COMPANY (US) | 1983-11-29 | — | — | US | disclosed |
| US-4407931-A | DIFFUSION TRANSFER | EASTMAN KODAK COMPANY (US) | 1983-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12037405-B2 | Anti-CD70 antibody drug conjugates | CD74, CD63, CD47 | IDO1 1101/4885CA12 875/4885CA9 1209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.